Results 161 to 170 of about 2,311,593 (264)
Circulating microRNA profiles distinguish nonmalignant Lynch syndrome from cancer‐associated Lynch syndrome, sporadic colorectal cancer, and healthy controls. Age‐stratified analysis reveals disease‐specific regulatory states, and a six‐miRNA panel shows concordant separation in an independent colorectal tissue cohort.
Ramadhani Salum Chambuso +5 more
wiley +1 more source
Zaščitna cepljenja v otroški dobi
A. Wallgren; priredba/adaptation Hermina Andoljšek
doaj
Perceived digital convenience and life satisfaction among older adults in China: a moderated mediation model of social adaptation and internet use. [PDF]
Song X, Wang Z, Dang Q, Wang H.
europepmc +1 more source
Use of Architectural Heritage: Challenges of Preservation and Adaptation
The problem of the 21st century heritage preservation is to raise the heritage to modern life. The study object is the adaptation of architectural heritage and ways of using it.
Riaubiene, Edita
core
Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba +5 more
wiley +1 more source
Dispanzerji in posvetovalnice za otroke v sr sloveniji
Marta Hočevar-Kuharič +1 more
doaj
Living Between Two Worlds: Reflections on Long-Term Brain Tumour Survivorship From a Patient-Researcher Perspective. [PDF]
Robertson J.
europepmc +1 more source
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David +12 more
wiley +1 more source
Engineering IL‐4 resistant proinflammatory human myeloid cells for cancer immunotherapy
We developed a scalable workflow to generate proinflammatory human myeloid cells. CRISPR/Cas9‐edited CD34+ hematopoietic stem and progenitor cells were expanded and differentiated with M‐CSF. Deletion of STAT6 or STAT6/NFKB1 enhanced macrophage proinflammatory gene expression and cytokine secretion in the presence of IL‐4 while maintaining antibody ...
Theresa Barberi, Alan D. Friedman
wiley +1 more source

